News & Updates
Filter by Specialty:
Dapagliflozin most effective in frail patients with heart failure
Treatment with dapagliflozin results in improvements in all outcomes, regardless of frailty status, among patients with symptomatic heart failure (HF) with reduced ejection fraction, reports a study. However, “more frail” patients have larger absolute reductions.
Dapagliflozin most effective in frail patients with heart failure
28 Apr 2022
Healthy lifestyle prolongs life, may prevent dementia onset
A healthy lifestyle among older men and women leads to a longer life expectancy, with freedom from Alzheimer’s dementia (AD) in their remaining years, a study has shown.
Healthy lifestyle prolongs life, may prevent dementia onset
28 Apr 2022
One in 10 patients fully recover from consciousness disorders after severe COVID-19
Among patients who suffer from disorders of consciousness (DoC) after severe COVID-19, around 10 percent can achieve functional independence after 1 year, reports a study presented at the recently concluded 2022 Annual Meeting of the American Academy of Neurology (AAN 2022).
One in 10 patients fully recover from consciousness disorders after severe COVID-19
28 Apr 2022
Annual flu jab in HF patients may lower hospitalization, pneumonia risk
An annual influenza vaccination does not lower the risk of cardiovascular (CV) outcomes in patients with heart failure (HF), though it may reduce the risk of pneumonia and hospitalization, according to results of the IVVE study presented at ACC.22.